AI in Life Sciences Has Entered Its Operational Era

AI in life sciences has entered its operational era

We’re no longer just talking about predictions, we’re seeing agentic AI systems that can reason, experiment, and even generate code.

This Averin Capital fireside conversation hosted by my partner David Berry brought together three people building that future: 🔹 Andrew Hopkins (XYME / Exscientia) 🔹 Jared Saul, MD (AWS) 🔹 Andrey Doronichev (Optic)

From synthetic biology to autonomous labs, what stood out to me was the shift from promise to practice. Worth your time if you care about where biotech and AI are actually converging.